Medicilon signed a strategic collaboration agreement with the North American 100 Angel Investment

On December 22, 2023, Medicilon and North America 100 Angel Investment LLC announced that the two parties had officially signed a strategic collaboration agreement in Boston.  In the future, the two parties will conduct diversified and in-depth cooperation in industrial investment, customer development, mergers and acquisitions, and industrial implementation support.  This collaboration will bring huge opportunities to both parties and promote the global development of both parties in the field of innovative drug research and development.

About North America 100 Angel Investment LLC
North America 100 Angel Investment LLC is registered in Massachusetts, USA.  The company focuses on the field of life sciences, including but not limited to medicine, equipment, medical services and other fields to promote the development of the life sciences industry through industrial investment, industry cultivation, project promotion, exhibition organization, consulting services and others.